| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/30/1993 | CA2013755C Medicinal emulsions |
| 11/30/1993 | CA1324758C Transdermal antisecretory agents for gastrointestinal disease |
| 11/30/1993 | CA1324757C Transdermal administration using benzyl alcohol |
| 11/27/1993 | CA2096902A1 Ophthalmic compositions containing vitamin e or ester thereof as an active ingredient |
| 11/27/1993 | CA2096889A1 Cyclopeptides and their use as absorption promoters when applied to the mucosa |
| 11/25/1993 | WO1993023570A1 Oligonucleotides having conjugates attached at the 2'-position of the sugar moiety |
| 11/25/1993 | WO1993023550A2 Activation of oligomerizing receptors by using fused receptor ligands |
| 11/25/1993 | WO1993023541A1 Hepatocyte growth factor variants |
| 11/25/1993 | WO1993023537A1 Chimeric multivalent protein analogues and methods of use thereof |
| 11/25/1993 | WO1993023457A1 Conversion of powdered polymers |
| 11/25/1993 | WO1993023445A1 Copolymers based on vinyl ethers and monoethylenically unsaturated dicarboxylic acid anhydrides, process for producing the same and their use |
| 11/25/1993 | WO1993023082A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 11/25/1993 | WO1993023080A1 Targeted activated species cytotoxicity |
| 11/25/1993 | WO1993023076A1 Alternative receptor therapy |
| 11/25/1993 | WO1993023065A1 Pharmaceutical compositions containing il-6 |
| 11/25/1993 | WO1993023062A1 Therapeutic conjugates of toxins and drugs |
| 11/25/1993 | WO1993023026A1 2-arylpropionic acid compositions and process for preparing the same |
| 11/25/1993 | WO1993023025A1 Transdermal administration of oxybutynin |
| 11/25/1993 | WO1993023022A1 Solid dispersion compositions of tebufelone |
| 11/25/1993 | WO1993023019A1 Transdermal drug delivery systems and related compositions and methods of use |
| 11/25/1993 | WO1993023017A1 Pharmaceutical and other dosage forms |
| 11/25/1993 | WO1993023010A1 Ophthalmic compositions containing a cyclosporin |
| 11/25/1993 | DE4216756A1 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung 2-arylpropionic acid preparations and methods for their preparation |
| 11/25/1993 | CA2135408A1 Chimeric multivalent protein analogues and methods of use thereof |
| 11/25/1993 | CA2131101A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 11/25/1993 | CA2118012A1 Hepatocyte growth factor variants |
| 11/25/1993 | CA2117893A1 Variant dimers for receptor activation |
| 11/24/1993 | EP0571264A1 Autoadhesive matrix system for the transdermal controlled release of piribedil |
| 11/24/1993 | EP0570829A1 Pharmaceutical composition for intravenous administration containing cyclosporin and method for its preparation |
| 11/24/1993 | EP0570682A1 Synthetic lipid A glycoconjugate antigens for use in vaccines |
| 11/24/1993 | EP0570606A1 Orally administrable solid medicine and process for preparing the same |
| 11/24/1993 | EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 11/24/1993 | EP0381763B1 Antibody modified with toxin |
| 11/24/1993 | CN1022839C Functionized polymine cheiants and rhodium complexes thereof and process for their preparation |
| 11/23/1993 | US5264618 For transport of biological active agents into cells for viral agents or polynucleotides or immunogenic peptides |
| 11/23/1993 | US5264550 Human anti-inflammatory phospholipase inhibitor protein |
| 11/23/1993 | US5264460 Process for preparing nonionic surfactants |
| 11/23/1993 | US5264422 Esters of alginic acid with steroidal alcohols |
| 11/23/1993 | US5264221 Liposomes with maleimide groups bonded to thiol groups in proteins for antitumor agents |
| 11/23/1993 | US5264220 Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 11/23/1993 | US5264207 Polymeric microspheres |
| 11/23/1993 | CA1324527C Lipidic emulsion for parenteral or enteral use |
| 11/20/1993 | CA2096511A1 Selfadhesive matricial system for the transdermal sustained liberation of piribedil |
| 11/18/1993 | EP0570356A1 Reagent for the determination of the activated partial thromboplastin time (aPII) |
| 11/18/1993 | EP0570327A1 Rapidly-dispersable compositions containing polydextrose |
| 11/18/1993 | EP0570232A2 Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol |
| 11/18/1993 | EP0570209A1 Production method of microcapsules |
| 11/18/1993 | EP0569583A1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 11/18/1993 | EP0569542A1 Interpenetrating-polymer network phase-transition gels |
| 11/18/1993 | EP0438426B1 Polylactide compositions |
| 11/18/1993 | EP0171407B1 Improvements relating to growth factors |
| 11/18/1993 | DE4216318A1 Copolymerisate auf Basis von Vinylethern und monoethylenisch ungesättigten Dicarbonsäureanhydriden, Verfahren zu ihrer Herstellung und ihre Verwendung Copolymers based on vinyl ethers and monoethylenically unsaturated dicarboxylic anhydrides, processes for their preparation and their use |
| 11/17/1993 | EP0641217A4 Amylase-electrolyte oral rehydration method and apparatus. |
| 11/17/1993 | CN1078401A Immunotoxins directed against CD33 related surface antigens |
| 11/17/1993 | CN1078400A Method for reducing side effects of a drug |
| 11/17/1993 | CN1078397A Chinese traditional medicine spirit "Yi-chai-bei" and preparation method thereof |
| 11/17/1993 | CN1078388A Treatment of disease employing hyuluronic acid and NSAIDS |
| 11/16/1993 | US5262522 Receptor for oncostatin M and leukemia inhibitory factor |
| 11/16/1993 | US5262404 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
| 11/16/1993 | US5262175 Stabilization of radiopharmaceutical compositions |
| 11/16/1993 | US5262165 Transdermal nitroglycerin patch with penetration enhancers |
| 11/16/1993 | US5262164 Insertion into or around the tooth cavity the drug monolein mixed with vitamins, antiiinflammatory agents, antibiotics, peroxides, anesthetic agents and microbactericides |
| 11/16/1993 | US5262150 Antifungus composition in dry spray form |
| 11/16/1993 | US5262087 Water-in-oil type emulsified composition |
| 11/16/1993 | CA2096212A1 Initiator of the intrinsic coagulationof blood, plasma or blood derivatives, a reagent for determining the aptt of blood, plasma or blood derivatives, a method of producing this reagent and a method of determining the aptt of samples of blood, plasma or blood derivatives |
| 11/15/1993 | CA2095424A1 Microporous polysulfone support suitable for removal of low density lipoprotein-cholesterol |
| 11/11/1993 | WO1993022677A1 Novel compounds and conjugates |
| 11/11/1993 | WO1993022433A2 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
| 11/11/1993 | WO1993022357A1 Use of copolymers of carboxylic acids and long-chained compounds with isolated multiple c-c bonds as thickening or dispersing agents |
| 11/11/1993 | WO1993022335A1 Stable polypeptide composition |
| 11/11/1993 | WO1993022332A2 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 11/11/1993 | WO1993021957A1 Complexing agents and targeting immunoreagents |
| 11/11/1993 | WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 11/11/1993 | WO1993021923A1 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 11/11/1993 | WO1993021912A1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
| 11/11/1993 | WO1993021909A1 Improved delivery formulation for lipophilic drugs |
| 11/11/1993 | WO1993021908A1 Collagen-containing sponges as drug delivery for proteins |
| 11/11/1993 | WO1993021907A1 Pharmaceutical preparation and process for its manufacture |
| 11/11/1993 | WO1993021906A1 Bioadhesive microspheres and their use as drug delivery and imaging systems |
| 11/11/1993 | WO1993021904A1 Retinoic acid-containing compositions |
| 11/11/1993 | WO1993021903A1 Use of borate-polyol complexes in ophthalmic compositions |
| 11/11/1993 | WO1993021901A1 Galenic form for ocular administration and process for the preparation of same |
| 11/11/1993 | WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 11/11/1993 | CA2135059A1 Complexing agents and targeting immunoreagents |
| 11/11/1993 | CA2134467A1 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 11/11/1993 | CA2134447A1 Collagen-containing sponges as drug delivery for proteins |
| 11/11/1993 | CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 11/11/1993 | CA2118508A1 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 11/11/1993 | CA2101734A1 Compounds and conjugates |
| 11/10/1993 | EP0569338A1 Administration system for estradiol |
| 11/10/1993 | EP0569113A1 Liposome compositions of porphyrin photosensitizers |
| 11/10/1993 | EP0568651A1 Biodegradable polymer blends for drug delivery |
| 11/10/1993 | EP0568631A1 Monoclonal antibodies to elam-1 and their uses |
| 11/10/1993 | EP0516704B1 Novel insulin compositions |
| 11/10/1993 | EP0440811B1 Composition for percutaneous administration |
| 11/10/1993 | CN1022666C Prepn. of solid pharmaceutical forms |
| 11/09/1993 | US5260433 Saccharide specific binding system labeled nucleotides |
| 11/09/1993 | US5260422 MHC conjugates useful in ameliorating autoimmunity |
| 11/09/1993 | US5260416 Antigenic epitopes present on membrane-bound but not secreted IgE |
| 11/09/1993 | US5260301 Pharmaceutical solution containing FK-506 |